Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension of rotigotine in advanced Parkinson's disease
NCT01631812Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Dec 2006
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rotigotine in Parkinson's disease (PD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Dec 2006; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01631812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631812.